Elanco and Sunstone Hotel beat third-quarter estimates and lift their annual outlooks

what happened

Elanco Animal Health reported third-quarter revenue of 1.27 billion dollars against an estimate of 1.21 billion from 11 analysts. Adjusted earnings per share came in at 0.27 dollars versus a consensus of 0.20. The company credits demand for pet health products, notably Zenrelia and Credelio Quattro, along with price increases of about 4%. It raised its 2026 revenue forecast to between 5.155 and 5.18 billion dollars and its adjusted EPS forecast to between 1.17 and 1.20 dollars.

U.S. lodging REIT Sunstone Hotel posted revenue of 233.72 million dollars against 223.04 million expected by six analysts. Adjusted FFO per diluted share climbed 17.6% year on year, and the company repurchased 117.8 million dollars of stock during the quarter. It now expects 2026 RevPAR growth of 9.5% to 10.5%, up from 7.0% to 9.0%. The figures are based on data from Reuters.

why it matters

For markets, the results point to durable demand for veterinary products and firm pricing in that segment, while US lodging revenue is accelerating. Sunstone's management said buybacks made at discounts also support per-share metrics. Both stories concern individual companies, so their reach beyond these stocks is limited.

market impact

Elanco and Sunstone shares: results above expectations support the two stocks

• ▲Elanco shares pressure up — quarterly revenue and adjusted profit beat consensus and guidance was raised
• ▲Sunstone Hotel shares pressure up — revenue beat estimates and the RevPAR outlook was raised sharply

tags

instruments